Austin Health
Austin Health
Melbourne, Australia5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2026-10-07 | NCT05243797 | |
| Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, biliary tract disorder, breast disorder, breast neoplasm, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, skin disorder, stomach disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-24 | NCT05523947 | |
| Adaptive RadioTherapy for OroPharynx Cancer | Deglutition Disorders, Digestive System Diseases, Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, digestive system disorder, esophageal disorder, injury, neoplasm, otorhinolaryngologic disease, radiation injury | Recruiting | Phase 2 | 2026-08-24 | NCT04901234 | |
| Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors | Advanced Renal Cell Carcinoma; Advanced Solid Tumor; Solid Tumor, Adult | Recruiting | Phase 1 | 2024-05-01 | NCT05868174 | |
| Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Not applicable | 2022-06-23 | NCT05136222 |